Brassard Maryse, AinMelk Youssef, Baillargeon Jean-Patrice
Division of Endocrinology, Department of Medicine, Université de Sherbrooke, 3001, 12th North Avenue, Sherbrooke, QC J1H 5N4, Canada.
Med Clin North Am. 2008 Sep;92(5):1163-92, xi. doi: 10.1016/j.mcna.2008.04.008.
Infertility in women has many possible causes and must be approached systematically. The most common cause of medically treatable infertility is the polycystic ovary syndrome (PCOS). This syndrome is common in young women and is the cause of anovulatory infertility in 70% of cases. It is therefore an important condition to screen and manage in primary care medical settings. In the past 10 years, insulin sensitization with weight loss or metformin has been shown to be a safe and effective treatment for PCOS infertility that eliminates the risk of multiple pregnancy and may reduce the risk of early pregnancy loss as compared with ovulation-inductor drugs. The authors believe metformin should be considered as first-line therapy because it has the advantage to allow for normal single ovulation, for reduced early pregnancy loss, and, most importantly, lifestyle modifications and weight loss before pregnancy. Losing weight not only improves fertility but also reduces adverse pregnancy outcomes associated with obesity.
女性不孕症有多种可能的原因,必须进行系统的诊断。在可通过医学手段治疗的不孕症中,最常见的原因是多囊卵巢综合征(PCOS)。这种综合征在年轻女性中很常见,在70%的病例中是无排卵性不孕症的病因。因此,在基层医疗环境中对其进行筛查和管理是一项重要工作。在过去10年中,通过减肥或使用二甲双胍来提高胰岛素敏感性已被证明是治疗PCOS不孕症的一种安全有效的方法,与促排卵药物相比,它消除了多胎妊娠的风险,并可能降低早期流产的风险。作者认为二甲双胍应被视为一线治疗药物,因为它具有使排卵正常、减少早期流产的优势,最重要的是,它有助于在怀孕前进行生活方式调整和减肥。减肥不仅能提高生育能力,还能减少与肥胖相关的不良妊娠结局。